Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers

Objective: To examine the associations between postmortem Alzheimer disease (AD) neuropathology and autopsy-verified cardiovascular disease. Methods: The authors examined 99 subjects (mean age at death = 87.6; SD = 8.7) from the Mount Sinai School of Medicine Department of Psychiatry Brain Bank who were devoid of cerebrovascular disease–associated lesions or of non–AD-related neuropathology. Density of neuritic plaques (NPs) and neurofibrillary tangles (NFTs) as well as coronary artery and aortic atherosclerosis, left ventricular wall thickness, and heart weight were measured. Partial correlations were used to assess the associations of the four cardiovascular variables with NPs and NFTs in the hippocampus, entorhinal cortex, and multiple regions of the cerebral cortex after controlling for age at death, sex, dementia severity, body mass index, and ApoE genotype. These analyses were also repeated separately for ApoE4 carriers and noncarriers. Results: The extent of coronary artery disease and to a lesser extent atherosclerosis were significantly associated with the density of cardinal neuropathologic lesions of AD in this autopsy sample (significant correlations between 0.22 and 0.29). These associations were more pronounced for the ApoE4 allele carriers (n = 42; significant correlations between 0.34 and 0.47). Conclusions: The degree of coronary artery disease is independently associated with the cardinal neuropathological lesions of Alzheimer disease. These associations are primarily attributable to individuals with the ApoE4 allele.

[1]  S. Reis,et al.  APOE polymorphism and angiographic coronary artery disease severity in the Women's Ischemia Syndrome Evaluation (WISE) study. , 2003, Atherosclerosis.

[2]  Hiroyuki Okada,et al.  Orthostatic posture affects brain hemodynamics and metabolism in cerebrovascular disease patients with and without coronary artery disease: a positron emission tomography study , 2005, NeuroImage.

[3]  Pei-Ning Wang,et al.  Weight loss, nutritional status and physical activity in patients with Alzheimer’s Disease , 2004, Journal of Neurology.

[4]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[5]  A. Thron,et al.  Dural arteriovenous fistulae at the foramen magnum , 2001, Journal of Neurology.

[6]  F. Grodstein,et al.  Apolipoprotein E, cardiovascular disease and cognitive function in aging women , 2005, Neurobiology of Aging.

[7]  P. Lai,et al.  Multi-Detector Row Computed Tomography Angiography in Diagnosing Spinal Dural Arteriovenous Fistula: Initial Experience , 2005, Stroke.

[8]  J. Poirier,et al.  Cholesterol and APOE genotype interact to influence Alzheimer disease progression , 2004, Neurology.

[9]  L. Thal,et al.  Clinical Dementia Rating training and reliability in multicenter studies , 1997, Neurology.

[10]  K. Schmader,et al.  Weight Change in Alzheimer's Disease , 1996, Journal of the American Geriatrics Society.

[11]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[12]  R. Mayeux,et al.  Atherosclerosis and AD , 2005, Neurology.

[13]  R. Mayeux,et al.  Cardiovascular risk factors and Alzheimer’s disease , 2004, Current atherosclerosis reports.

[14]  H. Soininen,et al.  Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. , 1995, Stroke.

[15]  Sanjay Asthana,et al.  Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender , 1999, Neuroendocrinology.

[16]  D. Sparks,et al.  Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease , 1990, Neurobiology of Aging.

[17]  L. Thal,et al.  Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. , 2000, Archives of neurology.

[18]  B. Winblad,et al.  Apolipoprotein E genotypes and the incidence of Alzheimer's disease among persons aged 75 years and older: variation by use of antihypertensive medication? , 2001, American journal of epidemiology.

[19]  K. Davis,et al.  Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. , 1998, Archives of neurology.

[20]  J. Seward,et al.  Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. , 2002, The American journal of cardiology.

[21]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[22]  K. Davis,et al.  Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease. , 2003, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[23]  B. Winblad,et al.  Therapeutic strategies for Alzheimer's disease based on new molecular mechanisms. , 2003, Acta neurobiologiae experimentalis.

[24]  Sudha Seshadri,et al.  Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease , 2002 .

[25]  K. Davis,et al.  Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. , 2000, Archives of neurology.

[26]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[27]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[28]  Donald T. Stuss,et al.  The Dementias , 1996, Brain and Cognition.

[29]  C. D. de Jager,et al.  APOE alleles predict the rate of cognitive decline in Alzheimer disease , 2005, Neurology.

[30]  H. Braak,et al.  Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.

[31]  I. Skoog,et al.  Hypertension, hypertension-clustering factors and Alzheimer's disease , 2003, Neurological research.

[32]  B. Sternfeld,et al.  Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. , 2000, JAMA.

[33]  U. Igbavboa,et al.  Recent advances in brain cholesterol dynamics: Transport, domains, and Alzheimer's disease , 1999, Lipids.

[34]  K. Davis,et al.  Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. , 1999, Archives of neurology.

[35]  M. Arto,et al.  beta-amyloid load is not influenced by the severity of cardiovascular disease in aged and demented patients. , 1999, Stroke.

[36]  Thomas G. Beach,et al.  Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer’s Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[37]  J. Schmeidler,et al.  Diabetes mellitus in midlife and the risk of dementia three decades later , 2004, Neurology.

[38]  B. Peterson,et al.  Estimating the validity of the Clinical Dementia Rating Scale: The CERAD experience , 1996, Aging.